Please login to the form below
New accounts: April
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period January 2005 to March 2005 inclusive.
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period January 2005 to March 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, e-mail websales@pmlive.com.
|
|
 |
|
|
|
3M Health Care |
Skin portfolio |
Wound care |
The Medical Multimedia Company |
|
Abbott Laboratories |
Kaletra |
HIV |
The Medical Multimedia Company |
|
AstraZeneca (Global) |
Zoladex |
Prostate cancer |
Tonic Life Communications |
|
Baxter Healthcare |
N/A |
Haemodialysis |
The Medical Multimedia Company |
|
Boehringer Ingelheim |
Mirapexin |
Parkinson's disease |
Lowe Fusion |
|
GE Healthcare |
New product |
Nuclear medicine |
Lowe Fusion |
|
GE Healthcare |
Steripet |
Nuclear medicine |
Lowe Fusion |
|
GSK/Roche |
Bonviva |
Osteoporosis |
Virgo Health PR |
|
Janssen-Cilag |
Tramacet |
Pain |
Lowe Fusion |
|
Lilly/Boehringer Ingelheim |
Yentreve nurse programme |
Incontinence |
Medicom Group |
|
Merck KGaA |
Erbitux |
Metastatic colorectal cancer |
Chandler Chicco Agency |
|
Napp Pharmaceuticals |
N/A |
Pain |
Axon Communications |
|
National Health Service |
Primary Care managers training programme |
N/A |
Medicom Group |
|
Pfizer |
Varenicline |
Smoking cessation |
Chandler Chicco Agency |
|
PM Society |
PRIME training programme |
N/A |
Helen Lawn & Associates |
|
Replay Media |
Corporate |
N/A |
Helen Lawn & Associates |
|
Sankyo Pharmaceuticals |
Olmetec |
Cardiovascular |
Kendle Healthcare |
|
sanofi-aventis |
Fasturtec |
Hyperuricaemia |
Discovery London |
|
sanofi-aventis |
Taxotere |
Oncology |
Discovery London |
|
sanofi-aventis |
Arava |
Arthritis |
Discovery London |
|
sanofi-aventis |
Xatral |
Benign prostatic hyperplasia |
Discovery London |
|
Schering-Plough |
Subutex |
Opioid dependence |
Discovery London |
|
Schering-Plough |
Viraferon-Peg |
Hepatitis C |
Discovery London |
|
Servier |
Procoralan |
Cardiology |
Shire Health London |
|
Straken |
Tostrex |
Hypogonadism |
Medicom Group |
|
Yamanouchi |
Flomax |
Benign prostatic hyperplasia |
Shire Health London |
Share
Related Hub content
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- Europe’s cancer community publishes new report on transforming patient care
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Locus Biosciences announces first patient treated in urinary tract infection trial
- World Health Organization releases latest set of COVID-19 guidelines
- Value proposition
PMHub
Page & Page and Partners
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
